Pharmacological treatment of type 2 diabetes mellitus is done by understanding the pathophysiology of the disease and mechanisms of drug action. The oral treatment of type 2 diabetes mellitus currently represents a challenge to physicians, as they face the breakdown of old paradigms, in addition to the technological, marketing and research have increased the current information to which the general practitioners and specialists have no access, such is the case of multiple studies of combined therapy with oral agents in type 2 diabetes mellitus.
In the past decade were conducted multiple intervention studies that showed that intensive glucose control dramatically lowers the risk of micro vascular complications in Type 1 and 2. The aim of these is to maintain the fasting glucose as close to normal and an HbA1c below 7.5%. (more…)
